FOLH1 and prostate cancer: The PSMA functionalized through hybridization and produced through TCL procedure attached the SPIONs to produce Apt-hybr-TCL-SPIONs, which showed preferential binding to the targeted prostate cancer cells (LNCaP) under in vitro and in vivo conditions with T(2)-weighted MRI imaging.